GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,546,000 | -6.8% | 81,457 | -6.7% | 0.01% | +25.0% |
| Q1 2022 | $3,805,000 | -0.7% | 87,339 | +0.5% | 0.00% | -20.0% |
| Q4 2021 | $3,831,000 | +25.2% | 86,873 | +0.7% | 0.01% | +25.0% |
| Q3 2021 | $3,061,000 | -13.4% | 86,270 | -2.8% | 0.00% | -20.0% |
| Q2 2021 | $3,535,000 | +14.1% | 88,756 | +2.3% | 0.01% | 0.0% |
| Q1 2021 | $3,097,000 | -56.7% | 86,783 | -55.4% | 0.01% | -16.7% |
| Q4 2020 | $7,156,000 | -80.8% | 194,450 | -80.4% | 0.01% | -91.2% |
| Q3 2020 | $37,261,000 | -10.2% | 989,914 | -2.7% | 0.07% | -19.0% |
| Q2 2020 | $41,503,000 | -21.7% | 1,017,492 | -26.7% | 0.08% | -34.9% |
| Q1 2020 | $52,988,000 | -39.2% | 1,388,332 | -25.2% | 0.13% | -24.6% |
| Q4 2019 | $87,187,000 | +4.7% | 1,855,829 | -4.9% | 0.17% | -4.5% |
| Q3 2019 | $83,266,000 | -7.6% | 1,950,948 | -13.3% | 0.18% | -9.1% |
| Q2 2019 | $90,092,000 | +3.2% | 2,251,170 | +7.8% | 0.20% | -1.5% |
| Q1 2019 | $87,267,000 | +17.3% | 2,088,214 | +7.2% | 0.20% | +3.6% |
| Q4 2018 | $74,400,000 | -3.4% | 1,947,128 | +1.6% | 0.19% | +12.9% |
| Q3 2018 | $76,996,000 | +48.8% | 1,916,771 | +49.3% | 0.17% | +39.0% |
| Q2 2018 | $51,745,000 | +784.5% | 1,283,678 | +757.2% | 0.12% | +1657.1% |
| Q1 2018 | $5,850,000 | +121.9% | 149,756 | +101.5% | 0.01% | +16.7% |
| Q4 2017 | $2,636,000 | -12.9% | 74,325 | -0.3% | 0.01% | -25.0% |
| Q3 2017 | $3,026,000 | +5.3% | 74,521 | +11.8% | 0.01% | 0.0% |
| Q2 2017 | $2,874,000 | -61.4% | 66,644 | -62.3% | 0.01% | -60.0% |
| Q1 2017 | $7,445,000 | -34.4% | 176,584 | -40.1% | 0.02% | -37.5% |
| Q4 2016 | $11,349,000 | -10.3% | 294,705 | +0.4% | 0.03% | -11.1% |
| Q3 2016 | $12,657,000 | -0.5% | 293,468 | +0.0% | 0.04% | -2.7% |
| Q2 2016 | $12,719,000 | +393.6% | 293,463 | +361.8% | 0.04% | +362.5% |
| Q1 2016 | $2,577,000 | +0.5% | 63,551 | +0.0% | 0.01% | 0.0% |
| Q4 2015 | $2,563,000 | -50.9% | 63,524 | -53.2% | 0.01% | -50.0% |
| Q3 2015 | $5,217,000 | -27.4% | 135,693 | -21.4% | 0.02% | -27.3% |
| Q2 2015 | $7,187,000 | -4.1% | 172,558 | +6.3% | 0.02% | -4.3% |
| Q1 2015 | $7,491,000 | +7.9% | 162,308 | -0.0% | 0.02% | +15.0% |
| Q4 2014 | $6,940,000 | -30.4% | 162,379 | -25.1% | 0.02% | -33.3% |
| Q3 2014 | $9,969,000 | -57.2% | 216,850 | -50.2% | 0.03% | -11.8% |
| Q2 2014 | $23,298,000 | +100.2% | 435,612 | +99.9% | 0.03% | 0.0% |
| Q1 2014 | $11,640,000 | -9.7% | 217,871 | -9.8% | 0.03% | -8.1% |
| Q4 2013 | $12,896,000 | -47.8% | 241,552 | -51.0% | 0.04% | -50.0% |
| Q3 2013 | $24,712,000 | -0.8% | 492,564 | -1.2% | 0.07% | -2.6% |
| Q2 2013 | $24,917,000 | – | 498,648 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |